EUVIMEDEUVIMED entdecken
Crossref

Prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immune-deficiency virus (HIV) infections among intravenous drug users (IDUs) in the MAH-o-MEHR Harm Reduction Center of Tehran , Iran

Ali Majidpour M. D

Journal of AIDS and HIV Research · 2012

DOI: 10.5897/jahr11.039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of AIDS and HIV Research, 2012. Verfasst von Ali Majidpour M. D.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intravenous drug users are considered to be at high risk of having the infections, hepatitis B virus (BBV), hepatitis C (HCV) and human immune-deficiency virus (HIV), because of their high risky behaviours especially of sharing of syringes. The objective of this study was to estimate the prevalence of BBV, HCV and HIV in intravenous drug users in a harm reduction center. A cross-sectional study was conducted in a sample of 118 cases of IDUs who were referred to Mah-o-Mehr Harm Reduction Center in Southern of Tehran in 2008. Information on sexual behaviour, socio-demographic and drug use variables were collected by means of a check list from their medical records. SPSS-15 software was used for data analysis and p-value

Zitieren

APA

D, A. M. M. (2012). Prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immune-deficiency virus (HIV) infections among intravenous drug users (IDUs) in the MAH-o-MEHR Harm Reduction Center of Tehran , Iran. Journal of AIDS and HIV Research. https://doi.org/10.5897/jahr11.039

Vancouver

D AMM. Prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immune-deficiency virus (HIV) infections among intravenous drug users (IDUs) in the MAH-o-MEHR Harm Reduction Center of Tehran , Iran. Journal of AIDS and HIV Research. 2012. doi:10.5897/jahr11.039

BibTeX
@article{D2012,
  author = {D, Ali Majidpour M.},
  title = {Prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immune-deficiency virus (HIV) infections among intravenous drug users (IDUs) in the MAH-o-MEHR Harm Reduction Center of Tehran , Iran},
  journal = {Journal of AIDS and HIV Research},
  year = {2012},
  doi = {10.5897/jahr11.039}
}
Kostenlos starten →